332 related articles for article (PubMed ID: 5190600)
1. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
Seghezzi R; Pedroni G; Borri P
Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
[No Abstract] [Full Text] [Related]
2. [The vasoactivogram in the treatment of peripheral arteriopathies].
Romeo S; Spinella G; Sciacchitanto D
Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
[No Abstract] [Full Text] [Related]
3. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
Zanelli G; Ferrero S; Patrone P
Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
[No Abstract] [Full Text] [Related]
4. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
Coscia M
Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
[No Abstract] [Full Text] [Related]
5. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
Shimamoto T; Atsumi T
Jpn Heart J; 1965 Sep; 6(5):407-15. PubMed ID: 5294603
[No Abstract] [Full Text] [Related]
6. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
[No Abstract] [Full Text] [Related]
7. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs].
Argenteri A; Bagliani A; Borri P; Ugolini U
Clin Ter; 1974 Aug; 70(3):281-91. PubMed ID: 4423739
[No Abstract] [Full Text] [Related]
8. Assessment of the efficacy of vasodilator drugs in peripheral vascular disease through a study of skeletal muscle metabolism using 31P nuclear magnetic resonance (NMR) spectroscopy.
Wahl D; Simon JP; Escanye JM; Jouanny P; Robin B; Walker P; Paille F; Schmidt C; Robert J; Schmitt J
Therapie; 1992; 47(2):125-6. PubMed ID: 1412138
[No Abstract] [Full Text] [Related]
9. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
Bagliani A; Borri P; Taborelli R
Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
[No Abstract] [Full Text] [Related]
10. [Experiences with the treatment of peripheral vascular diseases with Xavin].
Brücknerová O
Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
[No Abstract] [Full Text] [Related]
11. [Intra-arterial infusion therapy of patients with the ischemic syndrome in thrombo-obliterating diseases of the lower extremities in ambulatory conditions].
Savel'ev IuS
Vestn Khir Im I I Grek; 1990 Sep; 145(9):131-4. PubMed ID: 1962927
[No Abstract] [Full Text] [Related]
12. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
Bonessa C; Cremonini L
Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
[No Abstract] [Full Text] [Related]
13. [Therapeutic acquisitions on chronic obliterating peripheral arterial diseases of the lower limbs].
Guagliano G; Bagliani A; Borri P
Minerva Med; 1976 May; 67(25):1648-55. PubMed ID: 778666
[No Abstract] [Full Text] [Related]
14. [Vasodilator drugs and obliterating arterial diseases of the lower extremities].
Larsen OA; Lassen NA
Ugeskr Laeger; 1967 Sep; 129(36):1168-71. PubMed ID: 5598859
[No Abstract] [Full Text] [Related]
15. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
Giulini SM; Agus GB; De Cristoforo A
Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
[No Abstract] [Full Text] [Related]
16. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
Hansteen V; Lorentsen E
Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
[No Abstract] [Full Text] [Related]
17. Levodopa in the treatment of arterial insufficiency of the lower limbs. Clinical and rheographic trial.
Vaccaro E; Solitro A; Barba C
Arzneimittelforschung; 1973 Dec; 23(12):1793-8. PubMed ID: 4205907
[No Abstract] [Full Text] [Related]
18. [The medical treatment of chronic arteriopathies of the lower extremities and its limitations].
Aubert M
Angeiologie; 1964; 16(6):17-25. PubMed ID: 5877972
[No Abstract] [Full Text] [Related]
19. Hypervolemic treatment of the chronic obliterative arteriopathies of extremities.
Brassai Z; Koválszki P; Pop GH; Kiss K; Olosz E
Med Interne; 1986; 24(1):37-41. PubMed ID: 2422732
[TBL] [Abstract][Full Text] [Related]
20. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
Vittori C; Taborelli G; Taborelli R
Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172
[No Abstract] [Full Text] [Related]
[Next] [New Search]
